Benchmarking lung cancer mortality rates in current and former smokers

Chest

Volumn 126, Issue 6, 2004, Pages 1742-1749

  Bach, Peter B ^a,d   Elkin, Elena B ^a   Pastorino, Ugo ^b   Kattan, Michael W ^a   Mushlin, Alvin I ^c   Begg, Colin B ^a   Parkin, D Maxwell ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cancer screening; CT; Logistic models; Lung cancer; Risk assessment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; VALIDATION PROCESS;

EID: 10444278108     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.6.1742     Document Type: Article

References (24)

1. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99-105
2. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002; 165:508-513
3. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362:593-597
4. Marcus PM. Lung cancer screening: an update. J Clin Oncol 2001; 19:83S-86S
5. Kramer BS, Gohagan JK, Prorok PC. Cancer screening: theory and practice. New York, NY: Marcel Dekker, 1999
6. Bach PB, Kelley MJ, Tate RC, et al. Screening for lung cancer: a review of the current literature. Chest 2003; 123(suppl):72S-82S
7. Gibson L, Spiegelhalter DJ, Camilleri-Ferranti C, et al. Trends in invasive cervical cancer incidence in East Anglia from 1971-1993. J Med Screen 1997; 4:44-48
8. Kjellgren O. Mass screening in Sweden for cancer of the uterine cervix: effect on incidence and mortality. Gynecol Obstet Invest 1986; 22:57-63
9. Hakama M, Chamberlain J, Day NE, et al. Evaluation of screening programs for gynecological cancers. Br J Cancer 1985; 52:669-673
10. Woods WG, Gao RN, Shuster JJ, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002; 346:1041-1046
11. Schilling FH, Spix C, Berthold F, et al. Neuroblastoma screening at one year of age. N Engl J Med 2002; 346:1047-1053
12. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003; 95:470-478
13. Omenn GS, Goodman G, Thornquist M, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 1994; 54(suppl):2038s-2043s
14. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150-1155
15. Melamed MR. Lung cancer screening results in the National Cancer Institute New York study. Cancer 2000; 89(suppl):2356-2362
16. Tockman MS. Lung cancer screening: the Johns Hopkins study. Chest 1986; 89(suppl):324
17. Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, NY: Springer, 2001
18. Harrell FEJ, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-387
19. Efron B, Gong G. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat 1983; 37:36-48
20. Schumacher M, Hollander N, Sauerbrei W. Resampling and cross-validation techniques: a tool to reduce bias caused by model building? Stat Med 1997; 16:2813-2827
21. NCI Lung Cancer Screening Trial. The Cancer Letter, 2002; 28:24
22. Bach PB, Schrag D, Nierman DM, et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001; 98:3234-3240
23. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999; 130:515-524
24. Patel J, Bach PB, Kris MG. Lung cancer in women: a contemporary epidemic. JAMA 2004; 291:1763-1768